Pharmacology

Pharmacology is the study of how chemical substances interact with living systems. If substances have medicinal properties, they are considered pharmaceuticals. The field encompasses drug composition and properties, interactions, toxicology, therapy, and medical applications and antipathogenic capabilities.

Pharmacology

Pharmacology is the study of the action of drugs on a biologic system. It incorporates components of medicine and biology, and how they interact with each other.

How Nasal Spray Use and Overuse Affects the Nose

Importance of Pharmacology in Dentistry

Valproic Acid Pharmacology

What is Neuropharmacology?

What is a Dose-Response Curve?

Olanzapine Pharmacology

Morphine Pharmacology

Nicotine Pharmacology

Opioid Pharmacology

Drug Metabolism

Pharmacist Career

See more featured articles »

How Can Biochemistry Practices be made Virtual?

Synthetic and Patented Cannabinoids

What is Pharmacodynamics?

Pharmacology of Cannabinoid Receptors

What is Drug Absorption?

Hormone Pharmacology

Infliximab Pharmacology

Pharmacokinetics

Celebrex (Celecoxib) Pharmacology

What is Efficacy?

Drug Distribution

Pharmacology of CAR-T Cells

Warfarin Pharmacology

Metabolomics in Pharmacology

Calcitonin Pharmacology

Drug Excretion / Elimination

Psychopharmacology and Neuropsychopharmacology Research

DNA and Technology

What is Psychopharmacology?

Geriatric Pharmacology: Medication Management for an Aging Population

What is Toxicology?

Carboplatin Pharmacology

Halicin: The AI-Discovered Antibiotic That Fights Superbugs

What is Pharmacoepidemiology?

Bottom-Up Approach Overview

Haloperidol Pharmacology

What is Quantitative Systems Pharmacology (QSP) Modeling?

What is in Silico?

What Are Adaptogens-and Do They Actually Work?

Importance of Allostery in Pharmacology

Caffeine Pharmacology

Pharmacology of Paracetamol

Latest Pharmacology News and Research

Multi-center research initiative aims to improve glioblastoma patient outcomes

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center are part of a new multi-institution research effort aimed at improving care and outcomes for patients diagnosed with glioblastoma, one of the most aggressive and difficult-to-treat cancers.

8 May 2026

Chromosome abnormalities may help cancer cells resist treatment and spread

A new study led by NYU Langone Health researchers found that cancer cells are better able to resist treatments when they have an abnormal number of chromosomes, which are DNA strands wound up in bundles that control which genetic instructions are followed in each cell type.

7 May 2026

GADD45B promotes apoptosis in intestinal injury through DNA demethylation

Intestinal ischemia/reperfusion (I/R) injury is a common pathophysiological phenomenon that is widely present in various primary intestinal diseases and systemic critical illnesses, potentially leading to multiple organ dysfunction and failure, with high morbidity and mortality.

5 May 2026

NIH awards $3.9 million grant to develop a non-opioid pain treatment

The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health (NIH), has awarded a $3.9 million grant to a multi-institutional team led by scientists at Sanford Burnham Prebys Medical Discovery Institute to develop a non-opioid pain therapeutic and advance it into a Phase 1 clinical trial.

4 May 2026

Pretargeted radioimmunotherapy shows promise for colorectal cancer treatment

A new pretargeted radioimmunotherapy (PRIT) technique has been shown to be safe and effective in eradicating tumors from a preclinical colorectal cancer model.

30 Apr 2026

New research shows weight loss is possible without GLP-1

Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.

30 Apr 2026

Radiomics model enhances height prediction in girls after menarche

Menarche marks a major turning point in female development and usually signals that only limited height gain remains.

28 Apr 2026

Study finds season of entry impacts childhood obesity outcomes

Childhood obesity remains a major health challenge, and effective interventions often depend on more than nutritional advice or exercise plans alone.

28 Apr 2026

New insights into predicting myeloma drug response

Although patients with the same cancer diagnosis may respond very differently to treatment, clinicians still have limited tools at their disposal to predict who is most likely to benefit or suffer from a particular myeloma therapy.

28 Apr 2026

Detailed images reveal DNA repair mechanism in cancer-related proteins

Scientists have captured the most detailed structural images to date of a specific type of protein's DNA repair process, a finding that could reveal ways to inhibit the effects of BRCA1 and BRCA2 mutations that heighten the risk for breast, ovarian and other cancers.

28 Apr 2026

Rural and urban children face distinct mental health challenges

A study in Pediatric Investigation found that rural and urban children and adolescents tend to experience different mental health issues, with those living in the country showing more emotional problems and those in the city demonstrating more behavioral issues.

22 Apr 2026

Early genomic testing prevents years of inconclusive visits for pediatric patients

For many families, eight years of uncertainty meant repeated specialist visits, inconclusive genetic tests and the growing fear that a clear answer might never come. For nearly half of the children enrolled in the Telethon Undiagnosed Disease Program (TUDP), that wait is now over.

21 Apr 2026

Scientists disrupt key cancer proteins to target neuroblastoma

Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with each other.

20 Apr 2026

AP-1 proteins help cancer cells rewire genes to survive treatment

A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.

15 Apr 2026

Weill Cornell Medicine lays out a vision to prepare cancer scientists for the AI revolution

A team of Weill Cornell Medicine investigators is working to cross-train the next generation of cancer researchers in cancer biology and the use of artificial intelligence tools for research.

13 Apr 2026

Genetic variants may reduce effectiveness of popular diabetes drugs

More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who have certain genetic variants, according to a new study by Stanford Medicine scientists and their collaborators.

12 Apr 2026

Brain pathways combine memory and reward to guide behavior

New research from the University of Maryland, Baltimore County (UMBC) reveals how two different parts of the brain's memory center team up in a key reward region to help mice-and likely humans-combine memories of places and contexts with the drive to pursue rewards.

10 Apr 2026

Study outlines principles for using CAR immunotherapies to treat neurodegenerative diseases

A UAB research team defines the criteria that CAR immunotherapies for neurodegenerative diseases must meet to advance both conceptually and in trials, which are still at a very preliminary stage, in a review study published in the journal Trends in Pharmacological Sciences.

8 Apr 2026

Childhood trauma inspires research into brain repair and recovery

What began as a child's encounter with trauma has grown into a research programme committed to understanding recovery.

7 Apr 2026

Lactate modification fuels drug resistance and immune escape in cancer

Published in Current Molecular Pharmacology, a comprehensive review led by Yong Xu and colleagues from Shanghai Pulmonary Hospital explores the emerging role of lactylation, a post-translational modification driven by lactate, in lung cancer progression and drug resistance.

7 Apr 2026